{"id":"https://openalex.org/W2012131538","doi":"https://doi.org/10.1002/acr.21636","title":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long\u2010term followup","display_name":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long\u2010term followup","publication_year":2012,"publication_date":"2012-02-10","ids":{"openalex":"https://openalex.org/W2012131538","doi":"https://doi.org/10.1002/acr.21636","mag":"2012131538","pmid":"https://pubmed.ncbi.nlm.nih.gov/22328491"},"language":"en","primary_location":{"id":"doi:10.1002/acr.21636","doi":"https://doi.org/10.1002/acr.21636","is_oa":false,"landing_page_url":"https://doi.org/10.1002/acr.21636","pdf_url":null,"source":{"id":"https://openalex.org/S13698240","display_name":"Arthritis Care & Research","issn_l":"0893-7524","issn":["0893-7524","1529-0123","2151-464X","2151-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Care & Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113605035","display_name":"Jean Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4647051","display_name":"Universit\u00e9 de Picardie Jules Verne","ror":"https://ror.org/01gyxrk03","country_code":"FR","type":"education","lineage":["https://openalex.org/I4647051"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Jean Schmidt","raw_affiliation_strings":["Mayo Clinic, Rochester, Minnesota, USA. schmidt.jean@chu-amiens.fr","Mayo Clinic, Rochester, Minnesota","RECIF, Amiens University Hospital, INSERM, U\u20101088, and The Jules Verne University of Picardy, Amiens, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, Minnesota, USA. schmidt.jean@chu-amiens.fr","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"RECIF, Amiens University Hospital, INSERM, U\u20101088, and The Jules Verne University of Picardy, Amiens, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4647051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036065256","display_name":"Tanaz A. Kermani","orcid":"https://orcid.org/0000-0002-7335-7321","observed_orcids":["https://orcid.org/0000-0002-7335-7321"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanaz A. Kermani","raw_affiliation_strings":["Mayo Clinic Rochester Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023746937","display_name":"A. Kirstin Bacani","orcid":"https://orcid.org/0000-0002-1703-2346","observed_orcids":["https://orcid.org/0000-0002-1703-2346"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Kirstin Bacani","raw_affiliation_strings":["Mayo Clinic Rochester Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091454890","display_name":"Cynthia S. Crowson","orcid":"https://orcid.org/0000-0001-5847-7475","observed_orcids":["https://orcid.org/0000-0001-5847-7475"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia S. Crowson","raw_affiliation_strings":["Mayo Clinic Rochester Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052273654","display_name":"Eric L. Matteson","orcid":"https://orcid.org/0000-0002-9866-0124","observed_orcids":["https://orcid.org/0000-0002-9866-0124"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric L. Matteson","raw_affiliation_strings":["Mayo Clinic Rochester Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047878379","display_name":"Kenneth J. Warrington","orcid":"https://orcid.org/0000-0001-7708-2487","observed_orcids":["https://orcid.org/0000-0001-7708-2487"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth J. Warrington","raw_affiliation_strings":["Mayo Clinic Rochester Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4640,"currency":"USD","value_usd":4640},"apc_paid":null,"fwci":9.5269,"has_fulltext":false,"cited_by_count":135,"citation_normalized_percentile":{"value":0.98445224,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"64","issue":"7","first_page":"1079","last_page":"1083"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14015","display_name":"Otitis Media and Relapsing Polychondritis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/takayasu-arteritis","display_name":"Takayasu arteritis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9990000128746033},{"id":"https://openalex.org/keywords/refractory-vasculitis","display_name":"refractory vasculitis","score":0.8450000286102295},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.8970000147819519},{"id":"https://openalex.org/keywords/sustained-remission","display_name":"sustained remission","score":0.7770000100135803},{"id":"https://openalex.org/keywords/corticosteroid-tapering","display_name":"corticosteroid tapering","score":0.8510000109672546},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.8899999856948853},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6840000152587891},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9301486015319824},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7851662635803223},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.7356299757957458},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.7349959015846252},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.7179727554321289},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6858688592910767},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.6377506256103516},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.5913077592849731},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5100272297859192},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.4624076187610626},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4432118535041809},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42487871646881104},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.33223849534988403},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.2332165241241455},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2159023880958557}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013625","descriptor_name":"Takayasu Arteritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/acr.21636","doi":"https://doi.org/10.1002/acr.21636","is_oa":false,"landing_page_url":"https://doi.org/10.1002/acr.21636","pdf_url":null,"source":{"id":"https://openalex.org/S13698240","display_name":"Arthritis Care & Research","issn_l":"0893-7524","issn":["0893-7524","1529-0123","2151-464X","2151-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Care & Research","raw_type":"journal-article"},{"id":"pmid:22328491","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22328491","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis care & research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W42503291","https://openalex.org/W187278249","https://openalex.org/W1981729580","https://openalex.org/W2003199908","https://openalex.org/W2007228319","https://openalex.org/W2007486550","https://openalex.org/W2029530205","https://openalex.org/W2040741242","https://openalex.org/W2044258895","https://openalex.org/W2053038853","https://openalex.org/W2078299459","https://openalex.org/W2097074349","https://openalex.org/W2131882149","https://openalex.org/W2136655213","https://openalex.org/W2170856389","https://openalex.org/W4238228430","https://openalex.org/W4321429408"],"related_works":["https://openalex.org/W2094594594","https://openalex.org/W2097074349","https://openalex.org/W7099200240","https://openalex.org/W2313100771","https://openalex.org/W2029530205","https://openalex.org/W1999304143","https://openalex.org/W4405868791","https://openalex.org/W2321381783","https://openalex.org/W3206658118","https://openalex.org/W2101262058"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"report":[2],"a":[3,25,74,85],"single-center":[4],"experience":[5],"with":[6,17,29,38,73,154,164,248,258],"the":[7,58,99,105,205,223],"use":[8,100,106,117],"of":[9,27,43,61,79,89,101,107,152,174,186,204,231,263,277],"tumor":[10],"necrosis":[11],"factor":[12],"(TNF)":[13],"inhibitors":[14,156,166,221,250,271],"in":[15,168,171,180,256],"patients":[16,28,68,112,134,139,176,182,188,199,207,217,257,264],"Takayasu":[18],"arteritis":[19],"(TA).":[20],"METHODS:":[21],"We":[22,65],"retrospectively":[23],"studied":[24],"cohort":[26],"refractory":[30,259],"TA":[31,47],"evaluated":[32],"at":[33],"our":[34],"institution":[35],"and":[36,84,129,143,177,197,238,272],"treated":[37],"TNF":[39,102,108,155,165,214,220,249,270],"inhibitors.":[40,103,215],"American":[41],"College":[42],"Rheumatology":[44],"criteria":[45],"for":[46,50,222],"were":[48,189],"used":[49],"inclusion.":[51],"Disease":[52],"activity":[53],"was":[54,157],"assessed":[55],"according":[56],"to":[57,98,191],"National":[59],"Institutes":[60],"Health":[62],"criteria.":[63],"RESULTS:":[64],"included":[66,118],"20":[67,111,175],"(19":[69],"women,":[70],"17":[71],"white)":[72],"mean":[75],"\u00b1":[76,81],"SD":[77],"age":[78],"33":[80],"10.2":[82],"years":[83],"median":[86,150],"disease":[87,169,266],"duration":[88,151],"15.9":[90],"months":[91,159],"(interquartile":[92],"range":[93],"[IRQ]":[94],"2-32.7":[95],"months)":[96],"prior":[97],"Before":[104],"inhibitors,":[109],"all":[110],"received":[113,136,141,147],"prednisone.":[114,201],"Other":[115],"medication":[116],"methotrexate":[119],"(18":[120],"patients),":[121,124,128,237],"azathioprine":[122],"(5":[123],"mycophenolate":[125],"mofetil":[126],"(3":[127,131],"cyclophosphamide":[130],"patients).":[132,242],"Seventeen":[133],"(85%)":[135],"infliximab,":[137],"2":[138],"(10%)":[140],"adalimumab,":[142],"1":[144],"patient":[145],"(5%)":[146],"etanercept.":[148],"The":[149],"treatment":[153,247,275],"23.0":[158],"(IQR":[160],"8.7-38.9":[161],"months).":[162],"Treatment":[163],"resulted":[167],"remission":[170,179,209,255],"18":[172,206],"(90%)":[173],"sustained":[178,254],"10":[181,195],"(50%).":[183],"Ten":[184],"(83%)":[185],"12":[187],"able":[190],"taper":[192],"prednisone":[193],"below":[194],"mg":[196],"7":[198],"discontinued":[200,219,274],"However,":[202,261],"6":[203],"achieving":[208],"experienced":[210,265],"relapse":[211,267],"while":[212,268],"receiving":[213,269],"Eleven":[216],"(55%)":[218],"following":[224],"reasons:":[225],"relapse,":[226],"persistently":[227],"active":[228],"disease,":[229],"lack":[230],"corticosteroid-sparing":[232],"effect,":[233],"adverse":[234,278],"effects":[235],"(4":[236,241],"other":[239],"reasons":[240],"CONCLUSION:":[243],"In":[244],"this":[245],"study,":[246],"induced":[251],"remission,":[252],"including":[253],"TA.":[260],"33%":[262],"20%":[273],"because":[276],"events.":[279]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}